Uni-Bio Science Group Ltd

0690 - HK
Save to watchlist

Add to calculator
Overview
Stock analysis
Dividends
Fundamentals
Uni-Bio Science Group Ltd
0690
-
HK
Overview
Stock analysis
Dividends
Fundamentals

Stock overview

Save to watchlist
0690
Symbol
HK
Exchange

About stock

Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes.

The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.

Similar stocks

Report issue